- High energy usage on site
- Staff commuting emissions
- Waste generation
ITH Pharma Ltd
Greenhouse gas emissions & sustainability report data
In its 2023-05 to 2024-04 reporting, ITH Pharma Ltd disclosed greenhouse gas emissions of 553.11 tCO2e/year. By scope: Scope 1: 4.96 tCO2e/year; Scope 2: 252.86 tCO2e/year; Scope 3: 295.29 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
553.11 tCO2e/year
2023-05 to 2024-04
Waste
80.06 tons/year
2023-05 to 2024-04
📊 Emissions by Scope (2023-05 to 2024-04)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 4.96 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 252.86 tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 295.29 tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Reduced carbon emissions from 764.51 tonnes of CO2e in 2022/23 to 553.11 tonnes of CO2e in 2023/24
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce emissions by 47.78 tCO2e (6.25%) per year to achieve a 50% reduction by 2030
📅 Medium-term
- Achieve a 50% reduction in GHG emissions by 2030
🔭 Long-term
- Achieve Net Zero emissions by 2050
🌱 ESG Focus Areas
Climate Change